Source: Annual Congress 2007 - Interstitial lung disease: diagnostic and therapeutic novelties
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Levänen, J. Grunewald, A. Eklund, J. Wahlström, M. Nord (Stockholm, Sweden). Increased pulmonary Wnt signaling in patients with sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 1569

Member's Comments

No comment yet.

Related content which might interest you: Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011 Hedgehog pathway activation is altered in COPD patients Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 10s Year: 2004 Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Wnt signalling and parenchymal fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis Source: Eur Respir Rev, 29 (158) 190140; 10.1183/16000617.0140-2019 Year: 2020 Four-and-a-half-LIM-domain (FHL)-2 acts as an enhancer of TGF-beta signaling in pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007 Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: ERS Lung Science Conference 2016 Year: 2016 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 The lung epithelium is a prominent source of Wnt ligands and inhibitors in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 TGF-β and BMP signal transduction pathways in pulmonary hypertension Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD Year: 2003 LSC Abstract – Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD Source: Eur Respir J 2016; 47: 254-263 Year: 2016 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Defective p53-mediated pro-apoptotic pathway in idiopathic pulmonary fibrosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Dysregulation of TGF-β/BMP signaling in a monocrotaline model of pulmonary hypertension Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Wnt and TGF-beta signaling in lung development Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009